Yingchao Liu Selected Research

Yingchao Liu Research Topics

Disease

11	Glioma (Gliomas) 01/2022 - 01/2012
7	Neoplasms (Cancer) 01/2022 - 12/2012
3	Carcinogenesis 01/2022 - 01/2010
3	Ulcerative Colitis 01/2022 - 01/2021
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2020
3	Body Weight (Weight, Body) 06/2017 - 01/2013
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 05/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2015 - 06/2012
2	Prolactinoma (Prolactinomas) 03/2011 - 01/2010
1	Alzheimer Disease (Alzheimer's Disease) 07/2022
1	Amyloid Plaque 07/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Brain Diseases (Brain Disorder) 06/2021
1	Residual Neoplasm 01/2021
1	Hyperuricemia 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Diabetes Mellitus 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020
1	Lymphatic Metastasis 04/2020
1	Atrial Fibrillation 01/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 12/2017
1	Melanoma (Melanoma, Malignant) 12/2017
1	Necrosis 12/2017
1	Atopic Dermatitis (Atopic Eczema) 12/2015
1	Infections 02/2014
1	Soft Tissue Infections 03/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
3	MicroRNAs (MicroRNA)IBA 07/2022 - 05/2020
3	EnzymesIBA 01/2022 - 01/2018
3	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019 - 10/2016
3	Food Additives (Food Additive)IBA 06/2017 - 01/2013
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2012
2	Phosphotransferases (Kinase)IBA 04/2020 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 04/2020 - 03/2011
2	ProteomeIBA 03/2011 - 01/2010
1	shenling baizhu sanIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Mannose (D-Mannose)IBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Cell-Penetrating PeptidesIBA 01/2022
1	HydrogelsIBA 01/2021
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2021
1	CholesterolIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	GlypicansIBA 01/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020
1	Glucose Transporter Type 1IBA 01/2020
1	alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase IIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	bazedoxifeneIBA 01/2020
1	arginyl-glycyl-aspartic acidIBA 04/2019
1	Coloring Agents (Dyes)IBA 04/2019
1	lime (calcium oxide)FDA Link 01/2018
1	Gentian Violet (Violet, Crystal)FDA Link 12/2017
1	jugloneIBA 12/2017
1	LigandsIBA 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017
1	Activins (Activin)IBA 12/2017
1	azoreductaseIBA 10/2016
1	icariinIBA 12/2015
1	epimedii flavoneIBA 12/2015
1	CytokinesIBA 12/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2015
1	CalpainIBA 01/2015
1	Staphylococcus aureus RNAIIIIBA 02/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2013
1	BrevicanIBA 12/2012
1	NeurotoxinsIBA 06/2012
1	Fusidic Acid (Fucithalmic)IBA 03/2012
1	Biological ProductsIBA 01/2012
1	Prion ProteinsIBA 01/2012
1	Peptides (Polypeptides)IBA 03/2011
1	ProlactinIBA 01/2010

Therapy/Procedure

4	Therapeutics 06/2021 - 12/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
2	Drug-Eluting Stents 01/2021 - 05/2020
1	Plasma Exchange 06/2021
1	Immunotherapy 01/2021
1	Fecal Microbiota Transplantation 01/2021
1	Percutaneous Coronary Intervention 05/2020
1	Re-Irradiation 08/2018
1	Radiotherapy 01/2012
1	Lasers (Laser) 01/2010